MORRISVILLE, N.C.--(BUSINESS WIRE)--etrials® Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical solutions that optimize clinical-trial management and accelerate time-to-market, and Datasci, LLC announced that they have settled their pending litigation related to Datasci’s U.S. patent concerning the collection and validation of clinical trial data. Under the terms of the settlement, etrials has entered into a non-exclusive licensing arrangement and agreed to pay Datasci $1.75 million as an upfront license fee for its legacy EDC products ASFlash, QSCapture and WebCapture. In return, Datasci has agreed to dismiss its claims with prejudice and acknowledge that etrials’ current EDC 2.0 product is not subject to any future royalty obligations.
